Artikel ; Online: LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway.
2022 Band 22, Heft 1, Seite(n) 474
Abstract: Background: The Lauren classification of gastric tumors strongly correlates with prognosis ... The purpose of this study was to explore the specific molecular mechanism of Lauren classification ... Results: The WGCNA model demonstrated that blue cyan was highly correlated with the Lauren classification ...
Abstract | Background: The Lauren classification of gastric tumors strongly correlates with prognosis. The purpose of this study was to explore the specific molecular mechanism of Lauren classification of gastric cancer and provide a possible theoretical basis for the treatment of gastric cancer. Methods: We standardized the gene expression data of five Gene Expression Omnibus gastric cancer databases and constructed a Weighted Co-expression Network Analysis (WGCNA) model based on clinicopathological information. The overall survival (OS) and disease-free survival (DFS) curves were extracted from the Cancer Genome Atlas (TCGA) and GSE62254 databases. Western blotting was used to measure protein expression in cells and tissues. Scratch and transwell experiments were used to test the migration ability of tumor cells. Immunohistochemistry was used to measure tissue protein expression in clinical tissue samples to correlate to survival data. Results: The WGCNA model demonstrated that blue cyan was highly correlated with the Lauren classification of the tumor (r = 0.24, P = 7 × 10 Conclusion: LMOD1 is an oncogene associated with diffuse gastric cancer and can affect the occurrence and development of EMT by regulating the FAK-Akt/mTOR pathway. LMOD1 can therefore promote peritoneal metastasis of gastric cancer cells and can be used as a novel therapeutic target for gastric cancer. |
---|---|
Mesh-Begriff(e) | Autoantigens ; Cell Line, Tumor ; Cell Movement/genetics ; Cytoskeletal Proteins/genetics ; Humans ; Oncogenes ; Peritoneal Neoplasms/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Stomach Neoplasms/pathology ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism |
Chemische Substanzen | Autoantigens ; Cytoskeletal Proteins ; LMOD1 protein, human ; MTOR protein, human (EC 2.7.1.1) ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; TOR Serine-Threonine Kinases (EC 2.7.11.1) |
Sprache | Englisch |
Erscheinungsdatum | 2022-04-30 |
Erscheinungsland | England |
Dokumenttyp | Journal Article |
ZDB-ID | 2041352-X |
ISSN | 1471-2407 ; 1471-2407 |
ISSN (online) | 1471-2407 |
ISSN | 1471-2407 |
DOI | 10.1186/s12885-022-09541-0 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.